CHAMPIONS ONCOLOGY, INC. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $0 for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-07-27
- CHAMPIONS ONCOLOGY, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $181.00K.
- CHAMPIONS ONCOLOGY, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $0.00.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2026-04-30 | $0.00 10-K · filed 2026-07-27 |
| 2025-04-30 | $181.00K 10-K · filed 2026-07-27 |
| 2024-04-30 | $0.00 10-K · filed 2025-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |